(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol
- CAS No.
- 52522-55-1
- Chemical Name:
- (6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol
- Synonyms
- 8β-hydroxy-exo-THC;8β-hydroxy-exo-THC (exempt preparation);(6aR)-6aβ,7,8,9,10,10aα-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8β-diol;(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol;6H-Dibenzo[b,d]pyran-1,8-diol, 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-, (6aR,8R,10aR)-
- CBNumber:
- CB32259784
- Molecular Formula:
- C21H30O3
- Molecular Weight:
- 330.46
- MDL Number:
- MOL File:
- 52522-55-1.mol
- MSDS File:
- SDS
(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 39796 | 8β-hydroxy-exo-THC (exempt preparation) ≥98% | 52522-55-1 | 100μg | $168 | 2026-04-30 | Buy |
| Cayman Chemical | 37766 | 8β-hydroxy-exo-THC ≥98% | 52522-55-1 | 1mg | $299 | 2026-04-30 | Buy |
| Cayman Chemical | 37766 | 8β-hydroxy-exo-THC ≥98% | 52522-55-1 | 5mg | $1116 | 2026-04-30 | Buy |
| ChemScene | CS-1243430 | 8β-Hydroxy-exo-THC | 52522-55-1 | 1mg | $806 | 2026-06-04 | Buy |
| ChemScene | CS-1243430 | 8β-Hydroxy-exo-THC | 52522-55-1 | 5mg | $2417 | 2026-06-04 | Buy |
(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol Chemical Properties,Uses,Production
Description
8β-hydroxy-exo-THC is an analytical reference standard that is structurally similar to known phytocannabinoids. 8β-hydroxy-exo-THC is a metabolite of exo-THC .1 8β-hydroxy-exo-THC is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
Uses
8β-Hydroxy-exo-THC is a cannabinoid ether analogue with a weaker affinity for receptor sites, with an IC50 of 1.2 μM[1].
References
1. Harvey, D.J., and Brown, N.K. Comparative in vitro metabolism of the cannabinoids Pharmacol. Biochem. Behav. 40(3),533-540(1991).
(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol Preparation Products And Raw materials
Raw materials
Preparation Products
52522-55-1((6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol)Related Search:
1of2




